Table 3:
Comparison of cytokine levels between controls without CF (n=20) and pwCF (n=48) at baseline, and between pwCF at baseline and 6-months post-ETI
Control (at baseline) | pwCF (at baseline) | pwCF 6-months post-ETI | Control vs pwCF at baseline1 | pwCF at baseline vs. 6-months post-ETI2 | |
---|---|---|---|---|---|
p | p | ||||
IL-22 | 0.2 ±0.2 | 0.7 ±0.2 | 0.4 ±0.3 | 0.097 | 0.256 |
IL-23 | 0.9 ±0.7 | 1.8 ±3.9 | 2.1 ±5.8 | 0.167 | 0.595 |
IFN-γ | 3.7 ±2.4 | 4.7 ±5.7 | 4.9 ±4.8 | 0.283 | 0.838 |
IL-4 | 0.04 ±0.02 | 0.1 ±0.3 | 0.1 ±0.2 | 0.186 | 0.465 |
IL-6 | 0.4 ±0.2 | 1.2 ±1.3 | 0.6 ±0.9 | <0.001* | 0.002* |
IL-8 | 2.1 ±0.9 | 3.8 ±3.1 | 2.6 ±1.8 | 0.001* | 0.004* |
IL-10 | 0.2 ±0.2 | 2.1 ±6.7 | 2.5 ±8.4 | 0.056 | 0.214 |
IL-13 | 2.3 ±1.2 | 1.2 ±1.3 | 1.2 ±1.4 | 0.001* | 0.688 |
IL-17A | 0.6 ±0.2 | 1.8 ±1.3 | 1.3 ±1.0 | <0.001* | 0.004* |
independent t-test,
paired t-test
p ≤ 0.05